The annual meeting of the Infectious Diseases Society of America was held this year from Oct. 16 to 19 in Los Angeles, ...
Imagine falling seriously ill with an infection. Normally, we visit the doctor, are prescribed antibiotics, and after 7-10 days, we're back on our feet.
An international team of researchers has found that an antibiotic commonly prescribed for patients with liver disease, called rifaximin, has led to the global emergence of an almost untreatable form ...
Researchers at Intermountain Health have been awarded a $356,000 grant from Merck, a global science and technology company ...
Researchers from the University of Waterloo have developed a new technology that can hold an entire course of antibiotics in ...
A new study has found that an antibiotic for liver disease patients could expose them to greater risk of a dangerous superbug.